Results suggest that age, gender, tumour type, race, hepatic function, renal function, chemotherapeutic agents, and EGFR expression in tumour cells had no apparent impact on the pharmacokinetics of panitumumab
SUURONNETTOMUUKSIEN TORJUNTAA KOSKEVAT TOIMINTAPERIAATTEET JA NIILLE, JOITA ASIA KOSKEE, ANNETTAVAT TIEDOTEMEA0.3 EMEA0.3